SB
Shivakumar Balakrishnan
About Shivakumar Balakrishnan
Data last updated:
Shivakumar Balakrishnan is a Director at Fleming Laboratories Limited (since 2023), Managing Director at Shiva's Farma Casa Private Limited (since 2001) and Director at Fermac Bio Private Limited (since 2023), and holds 3 more current directorships. The companies operate in Pharma, Life Sciences and Financial Services. The 3 current companies with reported revenue have a combined latest revenue of ₹157 Cr; the largest is Fleming Laboratories Limited at ₹136 Cr (FY 2025). Earlier, Shivakumar Balakrishnan was a Director at Galt Pharma Exports Private Limited (2005–2021) and Director at Curie Laboratories Private Limited (from 2015) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Aug 2023 | 1992 | ₹136 Cr (FY 2025) | Active | |
| Managing Director | 20 Dec 2001 | 2001 | ₹21.44 Cr (FY 2025) | Active | |
| Director | 18 Aug 2023 | 2022 | ₹3.3 Lakh (FY 2025) | Active | |
| Additional Director | 16 Mar 2022 | 2021 | Active | ||
| Designated Partner | 12 Apr 2021 | 2021 | Active | ||
| Director | 26 Mar 2015 | 2015 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Jan 2005 | 2005 | ₹2.16 Cr (FY 2020) | Converted To Llp | |
| Director | 17 Apr 2015 | 2015 | Strike Off | ||
| Director | 06 Dec 2022 | 2022 | Strike Off | ||
| Director | 23 Aug 2023 | 2023 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shivakumar Balakrishnan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shivakumar Balakrishnan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shivakumar Balakrishnan
Shivakumar Balakrishnan currently holds 6 directorships: Fleming Laboratories Limited (Director, since 23 Aug 2023, revenue ₹136 Cr (FY 2025)); Shiva's Farma Casa Private Limited (Managing Director, since 20 Dec 2001, revenue ₹21.44 Cr (FY 2025)); Fermac Bio Private Limited (Director, since 18 Aug 2023, revenue ₹3.3 Lakh (FY 2025)); Scires Technologies Private Limited (Additional Director, since 16 Mar 2022); Galt Pharma Exports Llp (Designated Partner, since 12 Apr 2021); and 1 more.
Shivakumar Balakrishnan was first appointed on 20 Dec 2001 as Managing Director at Shiva's Farma Casa Private Limited. The most recent appointment on record is 23 Aug 2023 at Fleming Life Sciences Private Limited.
The 3 current companies of Shivakumar Balakrishnan that report revenue have a combined latest revenue of ₹157 Cr: Fleming Laboratories Limited ₹136 Cr (FY 2025); Shiva's Farma Casa Private Limited ₹21.44 Cr (FY 2025); Fermac Bio Private Limited ₹3.3 Lakh (FY 2025).
Shivakumar Balakrishnan held 4 earlier board appointments: Galt Pharma Exports Private Limited (Director, 07 Jan 2005 to 11 Apr 2021); Curie Laboratories Private Limited (Director, from 17 Apr 2015); Shipra Life Sciences Private Limited (Director, from 06 Dec 2022); Fleming Life Sciences Private Limited (Director, from 23 Aug 2023).
The current boards of Shivakumar Balakrishnan's companies include Jeyamuruga Prakash Manoharan (Fleming Laboratories Limited), Kesavamuralidhar Vadakattu (Fleming Laboratories Limited), Nadar Mariappa Veluchamy (Fleming Laboratories Limited), Navneet Kaur (Fleming Laboratories Limited), Nithyagovind (Fleming Laboratories Limited), Malathi Shivakumar (Shiva's Farma Casa Private Limited), among others.